1. Home
  2. AWI vs PTGX Comparison

AWI vs PTGX Comparison

Compare AWI & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AWI

Armstrong World Industries Inc

HOLD

Current Price

$154.96

Market Cap

7.0B

Sector

Industrials

ML Signal

HOLD

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$97.01

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AWI
PTGX
Founded
1860
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Plastic Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0B
6.4B
IPO Year
1994
2016

Fundamental Metrics

Financial Performance
Metric
AWI
PTGX
Price
$154.96
$97.01
Analyst Decision
Buy
Strong Buy
Analyst Count
6
13
Target Price
$207.50
$108.23
AVG Volume (30 Days)
342.4K
462.9K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
0.80%
N/A
EPS Growth
17.61
N/A
EPS
1.55
0.05
Revenue
$1,620,800,000.00
N/A
Revenue This Year
$10.32
$874.25
Revenue Next Year
$6.71
N/A
P/E Ratio
$98.55
$2,055.80
Revenue Growth
12.11
N/A
52 Week Low
$149.07
$49.86
52 Week High
$206.08
$107.84

Technical Indicators

Market Signals
Indicator
AWI
PTGX
Relative Strength Index (RSI) 38.19 47.17
Support Level $151.98 $96.36
Resistance Level $162.98 $104.85
Average True Range (ATR) 4.00 4.25
MACD -0.03 -0.26
Stochastic Oscillator 29.85 42.59

Price Performance

Historical Comparison
AWI
PTGX

About AWI Armstrong World Industries Inc

Armstrong World Industries Inc designs and manufactures exterior architectural applications, including ceilings, specialty walls, and exterior metal solutions, using materials such as mineral fiber, fiberglass, metal, felt, architectural resin and glass, wood, wood fiber, and glass-reinforced-gypsum. Its segments include Mineral Fiber, which produces suspended mineral fiber and fiberglass ceiling systems and includes results from the Worthington Armstrong Venture (WAVE) for ceiling suspension system (grid) products; Architectural Specialties, which designs, produces, and sources specialty ceilings, walls, and other architectural applications for commercial settings, with revenues mainly project driven; and Unallocated Corporate. The company operates in the United States and Canada.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Share on Social Networks: